Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

5 recruiting2 with results

Enrollment Performance

Analytics

N/A
5(55.6%)
Phase 1
2(22.2%)
Phase 4
1(11.1%)
Phase 2
1(11.1%)
9Total
N/A(5)
Phase 1(2)
Phase 4(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)